# Valsartan

## Diovan 80mg

| TAH Drug Code      | [ODIO](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ODIO)                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of hypertension in adults and children/adolescents aged 6-18 years， heart failure (NYHA Class II-IV)， and left ventricular dysfunction following myocardial infarction.                                                                                                                                                                                                                                                                                                                                                       |
| Dosing             | HTN Initial: 80 -160 mg QD; slowly titrate up to maximum 320 mg QD CHF with reduced ejection fraction 20 -40 mg BID; doubling dose， every 1 to 2 weeks to 160mg BID Acute coronary syndromes: initial: 20mg BID may tolerance up to 160mg BID.                                                                                                                                                                                                                                                                                           |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Contraindications  | Contraindicated in patients known to be allergic to any component of Diovan and in pregnant women. Contraindicated in combination with aliskiren-containing medications in diabetic patients or patients with renal impairment (GFR < 60 ml/min/1.73 m2).                                                                                                                                                                                                                                                                                 |
| Adverse Effects    | Headache， dizziness， viral infection， upper respiratory tract infection， diarrhea， coughing， fatigue， rhinitis， sinusitis， back pain， abdominal pain， nausea， pharyngitis， arthralgia. Cardiovascular: Hypotension Neurologic: Dizziness， Headache Renal: Serum blood urea nitrogen raised (heart failure， 16.6%; hypertension and post-myocardial infarction， not reported )， Serum creatinine raised (hypertension， 0.8%; heart failure， 3.9%; post-myocardial infarction， 4.2% ) Respiratory: Cough Other: Fatigue |
| Pregnancy          | Human Data Suggest Risk in 2nd and 3rd Trimesters                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| More Info          | [UpToDate](https://www.uptodate.com/contents/valsartan-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |

